Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw Aung, Jennifer J. Knox, Bernadette Southwood et al.|Clinical Cancer Research|2017Cited by 635
Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive CancerAlison M. Schram, Alexander Drilon, Kōichi Goto et al.|New England Journal of Medicine|2025Cited by 104
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J. Knox, Grainne M. O’Kane|Nature Communications|2025Cited by 21